Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
High blood pressure
Biotech
Mineralys drug lowers blood pressure in yet another clinical win
Mineralys’ aldosterone synthase inhibitor has chalked up a third clinical win in recent months.
James Waldron
Jun 17, 2025 9:25am
Mineralys stock jumps as hypertension drug posts double wins
Mar 10, 2025 9:13am
AI spots high blood pressure, diabetes in slow-motion video
Nov 18, 2024 11:30am
Medtronic claims long-sought FDA approval in renal denervation
Nov 20, 2023 10:21am
J&J hands back $230M blood pressure drug with approval in sight
Sep 6, 2023 6:20am
Medtronic, ReCor back renal denervation approach to hypertension
Sep 20, 2022 2:51pm
